Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: airtight package for oversea shipment
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000kgs
Port: BEIJING,SHANGHAI,QINGDAO
4-Chloro-7-methoxyquinoline-6-amide is a light yellow solid substance, used in laboratory research and development processes and chemical production processes, and is mainly used as an intermediate for levatinib. Levatinib is an oral multi-receptor tyrosine kinase inhibitor developed by Japan's Eisai Corporation (Eisai). It is a potential therapeutic drug for thyroid cancer, liver cancer, non-small cell lung cancer and other solid tumors.
PRODUCT 4-chloro-7-Methoxyquinoline-6-carboxaMide
CAS 417721-36-9
MF C11H9ClN2O2
MW 236.65
Product Categories : API Intermediates > Lenvatinib Mesylate Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.